Atosiban (CED0008356)

Record Information
Version1.0
Creation Date2016-05-22 06:55:06 UTC
Update Date2026-08-22 14:34:45 UTC
Accession NumberCHEM020206
Identification
Common NameAtosiban
ClassSmall Molecule
Description
Atosiban is an organic compound with the chemical formula C43H67N11O12S2. Atosiban belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 994.19 g/mol, Atosiban is a heavy molecule. The compound is recorded as being found in or released from two sources: electrical and electronic equipment antennas, and gynecological pharmaceuticals and veterinary products. The recorded route of exposure for this substance is intravenous. Atosiban acts upon four recorded protein targets, serving as an antagonist of the oxytocin receptor (OXTR), the vasopressin V1a receptor (AVPR1A), the vasopressin V1b receptor (AVPR1B), and the vasopressin V2 receptor (AVPR2).
Contaminant TypeNot Available
Chemical Structure
Synonyms
ValueSource
(2S)-5-Amino-2-({[(2S)-1-[(4R,7S,10S,13S,16R)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-6,9,12,15,18-pentahydroxy-7-[(C-hydroxycarbonimidoyl)methyl]-10-[(1R)-1-hydroxyethyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carbonyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-N-[(C-hydroxycarbonimidoyl)methyl]pentanimidateGenerator
1-deamino-2-Tyr(oet)-4-THR-8-orn-oxytocinMeSH
(Mpa(1),D-tyr(et)2,THR(4),orn(8))oxytocinMeSH
(Mpa(1)-D-tyr(et)(2)-THR(4)-orn(8))-oxytocinMeSH
AtosibanMeSH
Chemical FormulaC43H67N11O12S2
Average Molecular Mass994.190 g/mol
Monoisotopic Mass993.441 g/mol
CAS Registry Number90779-69-4
IUPAC Name(2S)-5-amino-2-({[(2S)-1-[(4R,7S,10S,13S,16R)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-6,9,12,15,18-pentahydroxy-7-[(C-hydroxycarbonimidoyl)methyl]-10-[(1R)-1-hydroxyethyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carbonyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-N-[(C-hydroxycarbonimidoyl)methyl]pentanimidic acid
Traditional Nameatosiban
SMILES[H][C@](C)(O)[C@]1([H])N=C(O)[C@@]([H])(N=C(O)[C@@]([H])(CC2=CC=C(OCC)C=C2)N=C(O)CCSSC[C@]([H])(N=C(O)[C@]([H])(CC(O)=N)N=C1O)C(=O)N1CCC[C@@]1([H])C(O)=N[C@@]([H])(CCCN)C(O)=NCC(O)=N)[C@@]([H])(C)CC
InChI IdentifierInChI=1S/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,55H,5-10,15-22,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,59)(H,48,58)(H,49,62)(H,50,64)(H,51,60)(H,52,61)(H,53,63)/t23-,24+,27-,28+,29-,30-,31-,35-,36-/m0/s1
InChI KeyVWXRQYYUEIYXCZ-OBIMUBPZSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as thia fatty acids. These are fatty acid derivatives obtained by insertion of a sulfur atom at specific positions in the chain.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassFatty Acyls
Sub ClassFatty acids and conjugates
Direct ParentThia fatty acids
Alternative Parents
Substituents
  • Thia fatty acid
  • Dicarboxylic acid or derivatives
  • Carboxylic acid salt
  • Carboxylic acid derivative
  • Carboxylic acid
  • Organic transition metal salt
  • Organic alkali metal salt
  • Hydrocarbon derivative
  • Organosulfur compound
  • Organooxygen compound
  • Organic oxide
  • Carbonyl group
  • Organic salt
  • Organic sodium salt
  • Organic oxygen compound
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External DescriptorsNot Available
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.065 g/LALOGPS
logP1.28ALOGPS
logP0.19ChemAxon
logS-4.2ALOGPS
pKa (Strongest Acidic)2.78ChemAxon
pKa (Strongest Basic)10.21ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count22ChemAxon
Hydrogen Donor Count13ChemAxon
Polar Surface Area392.08 ŲChemAxon
Rotatable Bond Count18ChemAxon
Refractivity276.15 m³·mol⁻¹ChemAxon
Polarizability102.62 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-05dj-4202040009-824b60c982cd25cc9c2dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00di-9100001002-73237722147477e25123Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00dl-7935000000-2478edd16a347f41e0b8Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-05fr-0000323009-f7d6a238de3049a95f32Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-007o-3211122009-919201da08018c06ab68Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0084-4972202342-6e884d2e072d0cd848a1Not AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity ValuesNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
316GynecologicalsHealthcare, pharmaceuticals & veterinary productsNot Available
506AntennasElectrical & Electronic EquipmentNot Available
Pathways
2 pathways
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureVasopressin V2 receptorQ00788Rattus norvegicusPredicted (SEA)132.966
Click to view 3D structureVasopressin V1a receptorP30560Rattus norvegicusPredicted (SEA)123.702
Oxytocin receptor structureClick to view 3D structureOxytocin receptorP30559HumansPredicted (SEA)134.056
Vasopressin V2 receptor structureClick to view 3D structureVasopressin V2 receptorP30518HumansPredicted (SEA)127.984
Click to view 3D structureVasopressin V1b receptorP47901HumansPredicted (SEA)114.75
Vasopressin V1a receptor structureClick to view 3D structureVasopressin V1a receptorP37288HumansPredicted (SEA)190.341
Click to view 3D structureVasopressin V1b receptorP48974Rattus norvegicusPredicted (SEA)99.0242
Click to view 3D structureOxytocin receptorP70536Rattus norvegicusPredicted (SEA)126.427
Click to view 3D structureVasopressin V2 receptorP32307Sus scrofaPredicted (SEA)82.9873
Click to view 3D structureSerine protease 1P00760Bos taurusPredicted (SEA)498.936
Click to view 3D structureEnvelope glycoprotein gp160P19550Human immunodeficiency virus type 1 group M subtype B (isolate SF162)(HIV-1)Predicted (SEA)76.6815
Trypsin-3 structureClick to view 3D structureTrypsin-3P35030HumansPredicted (SEA)77.3821
Cathepsin G structureClick to view 3D structureCathepsin GP08311HumansPredicted (SEA)408.319
Click to view 3D structureC5a anaphylatoxin chemotactic receptor 1P30993Mus musculusPredicted (SEA)244.213
T-cell surface antigen CD2 structureClick to view 3D structureT-cell surface antigen CD2P06729HumansPredicted (SEA)59.0876
Plasminogen structureClick to view 3D structurePlasminogenP00747HumansPredicted (SEA)1313.39
Telomeric repeat-binding factor 2 structureClick to view 3D structureTelomeric repeat-binding factor 2Q15554HumansPredicted (SEA)189.874
Suppressor of tumorigenicity 14 protein structureClick to view 3D structureSuppressor of tumorigenicity 14 proteinQ9Y5Y6HumansPredicted (SEA)681.336
Serine protease 1 structureClick to view 3D structureSerine protease 1P07477HumansPredicted (SEA)1107.02
Kallikrein-7 structureClick to view 3D structureKallikrein-7P49862HumansPredicted (SEA)137.326
Click to view 3D structureNeurotensin receptor type 1O88319Mus musculusPredicted (SEA)216.421
Prothrombin structureClick to view 3D structureProthrombinP00734HumansPredicted (SEA)2606.16
Neurotensin receptor type 1 structureClick to view 3D structureNeurotensin receptor type 1P30989HumansPredicted (SEA)514.583
Adapter molecule crk structureClick to view 3D structureAdapter molecule crkP46108HumansPredicted (SEA)195.791
Click to view 3D structureNeurotensin receptor type 1P20789Rattus norvegicusPredicted (SEA)214.864
Concentrations
Not Available
External Links
DrugBank IDNot Available
HMDB IDNot Available
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkNot Available
Chemspider IDNot Available
ChEBI IDNot Available
PubChem Compound ID5311010
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References